Dosing & Uses
AdultPediatric
See pediatric dosing
Duchenne Muscular Dystrophy
Gene therapy pending FDA approval for ambulant individuals with Duchenne muscular dystrophy
Next:
Pharmacology
Mechanism of Action
Gene transfer therapy intended to deliver delandistrogene moxeparvovec to muscle tissue for targeted production of functional components of dystrophin
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
